Neurocrine Biosciences Inc (NBIX)

Industry Drug Manufacturers - Specialty & Generic

This stock can be held in an Investment ISA and an Investment Account

Sell

$137.67

Buy

$165.00

arrow-down$-7.04 (-4.73%)

Prices updated at 17 Dec 2025, 23:43 EST

Prices minimum 15 mins delay

Prices in USD

Neurocrine Biosciences Inc engages in the discovery and development of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States.

NASDAQ

-1.81%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	$150.47 - $141.61
	$160.18 - $84.23
	-
	14,829.23m
	33.84
	-
	1,758,151
	4.71
	1,156,970.15
	0.61
	99.40m
	US64125C1099
	4.19
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.